This report provides:
- Worldwide overview of the molecular diagnostics market, including
France, Germany, Italy, Japan, Spain, UK and USA.
The report is available by section, and can be customized to specific information needs and budget.
- Estimates of facilities performing DNA sequencing and molecular diagnostic testing by country.
- Five-year test volume and sales forecasts by country.
Table of Contents
1 Worldwide Business Environment
2 Worldwide Market Structure
3 Worldwide Market Size and Growth
List of Tables
Table 1 Laboratories Performing DNA Sequencing By Country
Table 2 Molecular Diagnostics Market: Potential Laboratory Universe by Country
Table 3 Molecular Diagnostic Test Volume Forecasts by Country
Table 4 Molecular Diagnostics Market Forecasts by Country
Contains 15 pages and 4 tables
- Abbott
- Affymetrix
- Agilent Technologies
- Applied Gene Technologies
- Arca Biopharma
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Biotest
- Cepheid
- Decode Genetics
- Diadexus
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Exact Sciences
- Fujirebio
- Grifols
- Hologic
- Illumina
- LabCorp
- Leica Biosystems
- Li-Cor Biosciences
- Myriad Genetics
- Ortho-Clinical Diagnostics
- PerkinElmer
- Proteome Sciences
- Qiagen
- Roche
- Scienion
- Sequenom
- Shimadzu
- Siemens Healthineers
- Sierra Molecular
- Takara Bio
- Tecan Group
- Thermo Fisher
Inflammatory Disease Marker Tests - Medical Devices Pipeline Assessment, 2020 Summary Medical Devices sector report, “Inflammatory Disease Marker Tests - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Inflammatory Disease Marker Tests pipeline products with...
Major players in the oncology molecular diagnostics market are Abbott Diagnostics, Becton Dickinson, Cepheid, Danaher Corporation, Beckman Coulter, Leica Biosystems, Gen Probe (Hologic), Qiagen N.V., Roche Diagnostics, and Siemens Healthcare. The global oncology molecular diagnostics market is expected to decline from $5.58 billion...
The RNA analysis/transcriptomics market is projected to reach USD 8.7 billion by 2025 from USD 4.5 billion in 2020, at a CAGR of 13.9% during the forecast period. The growth of this market is majorly driven by the increasing demand for personalized medicine, increasing pharmaceutical and biotechnology R&D expenditure and government funding...
Genomics is the branch of biotechnology where different techniques of genetics and molecular biology are employed to map the DNA sequences of targeted genes or the complete set of genomes of interest and then organizing the results in the database and application of data in various fields. Genomics technologies are...
The Digital PCR market is projected to register a CAGR of nearly 17.8% over the forecast period. The major factor attributing to the growth of the market is the rising diagnostics and screening tests of diseases like cancer, hereditary, and infectious diseases, and the growing demand for parental testing and gene study. As per GLOBOCAN, the...
The Global Genomics Partnering Terms and Agreements 2014 to 2020 report provides an understanding and access to the Genomics partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in Genomics partnering deals Disclosed headlines, upfronts, milestones and royalties by stage...
Next Generation Sequencing Global Market Opportunities And Strategies 2020-30: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global next generation sequencing market. Description: Where is the largest and fastest growing...
In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global dPCR and qPCR Market Report The dPCR and qPCR market by revenue is expected to grow at a CAGR of over 9% during the period 2020–2025. The global digital PCR (dPCR) and the real-time PCR (qPCR) market is one of the dynamic and fast-growing...
The Asia Pacific single-cell analysis market is projected to reach USD 1,375 million by 2025 from USD 550 million in 2020, at a CAGR of 20.1% during the forecast period. Market growth is driven by factors such as growth in stem cell research, increasing R&D in the pharmaceutical and biotechnology industries for complex diseases, rising prevalence...
The nucleic acid amplification, detection, and diagnostics market was valued at US$ 14,014.59 million in 2019 and is projected to reach US$ 38,162.68 million by 2027; it is expected to grow at a CAGR of 13.4% during 2020–2027. The growth of the nucleic acid amplification, detection, and diagnostics market is mainly attributed to the factors...